Study to Evaluate Suppression of Ovulation and Pharmacokinetics of Medroxyprogesterone Acetate Following Administration of TV-46046 in Women With Ovulatory Cycle

Inclusion Criteria: * has regular menstrual cycle (24 to 35 days) * is at low risk of pregnancy (ie, sterilized, in exclusively same-sex partnership, in monogamous relationship with vasectomized partner, or using non-hormonal IUD) * is in good general health as determined by a medical history and physical examination * is not pregnant and does not have desire to become pregnant in the subsequent 36 months * has had a normal mammogram within the last year (for Part 1 only) * additional criteria apply, please contact the investigator for more information Exclusion Criteria: * has hypertension: * systolic blood pressure (BP) ≥160 mm Hg or diastolic BP ≥100 mm Hg * vascular disease * has current or history of ischemic heart disease * has history of stroke * has history of thromboembolic event * has systemic lupus erythematosus * positive (or unknown) antiphospholipid antibodies * severe thrombocytopenia * has rheumatoid arthritis on immunosuppressive therapy * has migraine with aura * has unexplained vaginal bleeding * has diabetes * has strong family history of breast cancer (defined as one or more first degree relatives, breast cancer occurring before menopause in three or more family members, regardless of degree of relationship, and any male family member with breast cancer), or current or history of breast cancer, or undiagnosed mass detected by breast exam * has current or history of cervical cancer * has severe cirrhosis (decompensated) or liver tumors * ha…